Global Markets and Manufacturing Technologies for Protein Drugs

Report Code: BIO021G

Publish Date: Apr 2025

Publisher: BCC Publishing

Category: Cell Biology

Download Report OverviewTARIFF UPDATE

Limited Period Offer

CUSTOMIZE NOW

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The global protein drugs market is expected to grow from $441.7 billion in 2024 and is projected to reach $655.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.2% during the forecast period of 2024 to 2029.

Report Includes

  • 79 data tables and 57 additional tables
  • An analysis of the global markets for protein drugs and their manufacturing technologies
  • Analyses of the global market trends, with revenue data for 2021 to 2023, estimates for 2024, and projected CAGRs through 2029
  • Estimates of the size of and revenue prospects for the global market, along with a market share analysis by type of protein drug, manufacturing technology, and region
  • Facts and figures pertaining to the market dynamics, technological advances, regulations, and the impact of macroeconomic factors
  • Insights derived from the Porter’s Five Forces model, as well as global supply chain and PESTLE analyses
  • Analysis of the advances in manufacturing technologies, disease prevalence trends, new products , and the impact of biosimilars entering the market for protein drugs
  • An analysis of patents and significant patent grants
  • Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, and the ESG scores and practices of leading companies
  • Analysis of the industry structure, including companies’ market shares and rankings, strategic alliances, M&A activity and a venture funding outlook
  • Profiles of leading companies, including AbbVie Inc., Bristol Myer Squibb, Merck & Co., Novo Nordisk S/A, Sanofi, and Roche

Report Scope

The report analyzes trends in the global market for protein drugs and manufacturing technologies. The report includes global revenue ($ millions) for the base year of 2023 and estimated data for the forecast period of 2024 through 2029. The market is segmented by product type/subtype, manufacturing technology and region. The regions covered are North America, Europe, Asia-Pacific and the Rest of the World, focusing on major countries in these regions.

The report focuses on the trends and challenges that affect the market and the vendor landscape. It analyzes environmental, social, and corporate governance (ESG) developments and discusses patents and emerging technologies related to the market.

The report concludes with an analysis of the competitive landscape, which provides the rankings and market shares of leading companies in the protein drug market. It also has a section of company profiles that shows financials, product portfolios and recent developments.

Report Synopsis

Report Metrics Details
Base year considered 2023
Forecast period considered 2024-2029
Base year market size $409.2 Billion
Market size forecast $655.7 Billion
Growth rate CAGR of 8.2% for the forecast period of 2024-2029
Units considered $ Millions
Segments covered Type, Manufacturing Technology, and Region
Regions covered North America, Asia-Pacific, Europe, Rest of the World
Countries covered U.S., Canada, Mexico, France, Germany, the U.K., Italy, Spain, Japan, India, China, South America, and Middle East and Africa
Key Market Drivers
  • Advances in manufacturing technologies.
  • Product launches.
  • Increasing incidence of cancer.
  • Licensing and collaboration agreements.Increasing number of approvals for mAb drugs.
Companies studied
ABBVIE INC.AMGEN INC.
ASTRAZENECA BAYER AG
BRISTOL-MYERS SQUIBB CO.F. HOFFMANN-LA ROCHE LTD.
JOHNSON & JOHNSON SERVICES INC.LILLY
MERCK & CO. INC.NOVARTIS AG
NOVO NORDISK A/SPFIZER INC.
REGENERON PHARMACEUTICALS INC.SANOFI
TAKEDA PHARMACEUTICAL CO. LTD.
Need pricing for multiple titles, a complete report bundle, or something specially curated to fit your budget? EXPLORE OFFERS

Frequently Asked Questions (FAQs)

The global protein drugs market is valued at an estimated $409.2 billion in 2023 and is slated to reach $655.7 billion by the end of 2029.
Advancements in manufacturing technologies.
  • Incessant number of new product launches.
  • Increasing incidence of cancer.
  • Licensing and collaboration agreements.
  • Increasing number of approvals for monoclonal antibodies drug type.
The report will provide information on protein drugs, their manufacturing technologies, and their growth projections in the coming years. Based on drug type, the market segments include monoclonal antibodies, peptide hormones, vaccines, blood factors, cytokines, therapeutic enzymes, peptide antibiotics, and fusion protein, with each type further sub-segmented into product types. Protein drug manufacturing technologies covered in the report include cell culture, microbial fermentation, natural source, embryonated egg, chemical synthesis, and transgenics. Information about macroeconomic factors, ESG analysis, and competitive analysis have been provided in the report. The report also identifies promising regions where the established players can plausibly expand their business.
The monoclonal antibodies segment dominates the protein drugs market and will continue to do so by 2029.
North America holds the highest share of the market.

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Global Markets and Manufacturing Technologies for Protein Drugs162Free
Chapter- 1: Executive Summary4Free
Chapter- 2: Market Overview10Free
Chapter- 3: Market Dynamics6Free
Chapter- 4: Regulatory Landscape2Free
Chapter- 5: Emerging Technologies3Free
Chapter- 6: Market Segment Analysis60Free
Chapter- 7: Competitive Intelligence10Free
Chapter- 8: Sustainability in the Protein Drug Market: ESG Perspective7Free
Chapter- 9: Appendix60Free
Published - Sep-2021| Analyst - BCC Publishing| Code - BIO021F

Report Highlights

The global protein drugs market should reach $394.2 billion by 2026 from $265.0 billion in 2021 at a compound annual growth rate (CAGR) of 8.3% for the forecast period of 2021 to 2026.

Report Includes

  • 37 data tables and 28 additional tables
  • An overview of the global markets and manufacturing technologies for protein drugs
  • Estimation of the market size and analyses of global market trends, with data from 2019 to 2020, estimates for 2021 with projections of compound annual growth rates (CAGRs) through 2026
  • Highlights of the current and future market potential and quantification of protein drugs market based on type, manufacturing process and region
  • Identification of market drivers, restraints and other forces impacting the global market and evaluation of current market size and forecast
  • Detailed description of protein drugs, their classification and six main manufacturing technologies and information on recombinant deoxyribonucleic acid (rDNA) technology
  • Information on advancements in manufacturing technologies, new product launches of the industry and discussion on effect of biosimilars entry to the protein drugs market
  • Detailed analysis of the regulatory framework and policies and technological changes within the industry
  • Market share analysis of the key companies of the industry and coverage of their proprietary technologies, strategic alliances, and other key market strategies and a relevant patent analysis
  • Comprehensive company profiles of the leading players of the industry, including AbbVie Inc., Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck & Co., Pfizer Inc. and Sanofi S.A.
Published - May-2016| Analyst - Shalini Shahani Dewan| Code - BIO021E

Report Highlights

The global protein drugs market reached nearly $174.7 billion in 2015 and should reach nearly $248.7 billion by 2020 at a compound annual growth rate (CAGR) of 7.3% through 2020.

Report Includes

  • An overview of the markets for each major class of protein in the segments therapeutic monoclonal antibodies, cytokines, peptide hormones, vaccines, and blood products
  • Analyses of global market trends, with data from 2014, estimates for 2015, and projections of compound annual growth rates (CAGRs) through 2020
  • Discussion covering the strength and weaknesses of each type of technology in light of the new technologies, growing competition, and changing customer needs
  • Examinations of current successes, including the size and sales forecast for each class in the next five years
  • Evaluation of challenges such as delivery methods and side effects
  • Consideration of issues regarding add-on products and patent protection
  • Company profiles of major players
Published - Oct-2013| Analyst - Shalini Shahani Dewan| Code - BIO021D

Report Highlights

The global protein therapeutics market reached $138.3 billion in 2012. This market is expected to decline to $136.7 billion in 2013 and then increase to nearly $179.1 billion in 2018, a compound annual growth rate (CAGR) of 5.6% over the five-year period from 2013 to 2018.

Report Includes

  • An overview of the markets for each major class of protein in the segments therapeutic monoclonal antibodies, cytokines, peptide hormones, vaccines, and blood products
  • Analyses of global market trends, with data from 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018
  • Examinations of current successes, including the size and sales forecast for each class in the next five years
  • Discussion of challenges such as delivery methods and side effects
  • Consideration of issues regarding add-on products and patent protection
  • Comprehensive company profiles of major players.
Published - Oct-2008| Analyst - Amy Brock| Code - BIO021C

Report Highlights

  • The global market for protein drugs is expected to increase from $86.8 billion in 2007 to an estimated $95.2 billion in 2008 and $160.1 billion in 2013, a compound annual growth rate (CAGR) of 10.9%.
  • Peptide hormones generated $26.1 billion in 2007 and an estimated $27.9 billion in 2008. This segment should reach $50.4 billion in 2013, for a CAGR of 12.6%.
  • The antibodies segment was worth $15.0 billion in 2007. This is expected to increase to $18.1 billion in 2008 and $36.9 billion in 2013, for a CAGR of 15.4%.
Published - Jul-2000| Analyst - Rahul Jasuja| Code - BIO021B

Report Highlights

  • Protein drugs for human therapeutic use are a 1,000 metric ton industry-more than one billion grams of bulk proteins that garnered formulation sales, on average, of $27.80 per gram in 1999. This study estimates 1,048,859,344 grams of bulk drug proteins were produced worldwide in 1999. Approximately 1,150,573,386 grams will be produced worldwide in 2004, representing an overall 1.9% average annual (compound) growth rate from 1999 to 2004.
  • Recombinant biological methods provided only 0.1% of the worldwide total bulk drug protein production in 1999, but are projected to provide 0.6% of the total production in 2004.

Related Reports

Biologic Therapeutic Drugs: Technologies and Global Markets

Published - May 2025 | Publisher - BCC Publishing | Code - BIO079F

The global market for biologic therapeutic drugs is estimated to increase from $499.2 billion in 2024 to reach $794.5 billion by 2029, at a compound annual growth rate (CAGR) of 9.7% from 2024 through 2029.

Antibody Drugs: Technologies and Global Markets

Published - Sep 2024 | Publisher - BCC Publishing | Code - BIO016M

The global market for antibody drugs is expected to grow from $242.6 billion in 2024 and is projected to reach $412.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.2% during the forecast period of 2024 to 2029.

Global Markets for Bioengineered Protein Drugs

Published - Apr 2023 | Publisher - BCC Publishing | Code - BIO009H

The global market for bioengineered protein drugs is estimated to increase from $354.1 billion in 2022 to reach $521.3 billion by 2027, at a compound annual growth rate (CAGR) of 8.0% from 2022 through 2027.

Global Markets for Blood Plasma Products

Published - Mar 2023 | Publisher - BCC Publishing | Code - HLC201C

The global blood plasma products market should reach $45.7 billion by 2027 from $33.2 billion in 2022 at a compound annual growth rate (CAGR) of 6.6% for the forecast period of 2022 to 2027.

Recent Reports

Human Microbiome-based Drugs and Diagnostics: Global Markets

Published - May 2025 | Publisher - BCC Publishing | Code - BIO151B

The global market for human microbiome-based drugs and diagnostics is expected to grow from $393.4 million in 2025 to reach $1.2 billion by the end of 2030, at a compound annual growth rate (CAGR) of 25.6% from 2025 through 2030.

Global Microbiome Sequencing Market

Published - May 2025 | Publisher - BCC Publishing | Code - BIO183B

The global microbiome sequencing market is expected to grow from $1.5 billion in 2024 and is projected to reach $3.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 19.3% during the forecast period of 2024 to 2029.

Proteomics: Technologies and Global Markets

Published - May 2025 | Publisher - BCC Publishing | Code - BIO034G

The global market for proteomic technologies was valued at $27.6 billion in 2024. It is projected to grow from $31.0 billion in 2025 to $57.2 billion by the end of 2030, at a compound annual growth rate (CAGR) of 13.0% from 2025 to 2030.

Biologic Therapeutic Drugs: Technologies and Global Markets

Published - May 2025 | Publisher - BCC Publishing | Code - BIO079F

The global market for biologic therapeutic drugs is estimated to increase from $499.2 billion in 2024 to reach $794.5 billion by 2029, at a compound annual growth rate (CAGR) of 9.7% from 2024 through 2029.

Global Markets and Manufacturing Technologies for Protein Drugs

Published - Apr 2025 | Publisher - BCC Publishing | Code - BIO021G

The global protein drugs market is expected to grow from $441.7 billion in 2024 and is projected to reach $655.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.2% during the forecast period of 2024 to 2029.

Top Trending Reports

Global Markets for Emerging Medical Device Technologies

Published - Mar 2025 | Publisher - BCC Publishing | Code - HLC191C

The global market for emerging medical devices is estimated to increase from $136.6 billion in 2024 to reach $223.9 billion by 2029, at a compound annual growth rate (CAGR) of 10.4% from 2024 through 2029.

Global Diabetic Care Devices Market

Published - Feb 2025 | Publisher - BCC Publishing | Code - MDS019B

The global market for diabetes monitoring devices is expected to grow from $16.6 billion in 2024 to $26.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.1% from 2024 through 2029.

Global Lithium-ion Battery Market

Published - Mar 2025 | Publisher - BCC Publishing | Code - FCB067A

The global market for lithium-ion battery (LIB) is expected to grow from $117.8 billion in 2024 and is projected to reach $221.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 13.5% during the forecast period of 2024 to 2029.

Generative AI: Global Markets

Published - Jan 2025 | Publisher - BCC Publishing | Code - IFT308A

The global market for generative AI was valued at $15.4 billion in 2023. It is projected to grow from $20.8 billion in 2024 to $94.4 billion by 2029, at a compound annual growth rate (CAGR) of 35.3% from 2024 through 2029.

2024 Medical Devices Research Review

Published - Mar 2025 | Publisher - BCC Publishing | Code - MDS060B

The medical device industry is a multi-billion-dollar industry whose outlook is supposed to rise in the coming years These devices treat and diagnose a multitude of patient conditions and work much better than drugs.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Global Markets and Manufacturing Technologies for Protein Drugs
Sample Report